Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
Critical candy recall hits New York ahead of Halloween festivities. Multiple popular brands removed from shelves due to serious undeclared allergen risks. Full details inside.
Federal health officials are accelerating efforts to bring cheaper biotech drugs to market, potentially transforming treatment access and creating new opportunities for Indian pharmaceutical companies.
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
Breaking news: The FDA has approved Veozah (fezolinetant), a groundbreaking non-hormonal treatment for moderate to severe hot flashes during menopause. Discover how this game-changing medication works and when Indian women can access it.
Breakthrough FDA approval offers new hope for women suffering from menopausal symptoms. Discover the first hormone-free oral medication that targets brain receptors for effective relief.
Discover why prominent investor Mukul Agrawal is betting big on a small-cap pharma company with massive growth potential. Get exclusive insights into his latest portfolio move and what it means for retail investors.
Popular Neutrogena Makeup Remover Cleansing Tows recalled after FDA detects dangerous Pluralibacter gergoviae bacteria. Here's what Indian consumers need to know about the product safety alert.
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
Critical medication alert: Major pharmaceutical recall announced after FDA testing reveals cholesterol-lowering pills may not dissolve properly, potentially compromising effectiveness.
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Major Coca-Cola recall underway as FDA discovers contaminated Coke and Sprite cans. Learn about the health risks and batch numbers affected in this developing story.
Indian pharmaceutical giant Cipla announces landmark deal with Eli Lilly to manufacture and distribute popular weight loss medications Mounjaro and Zepbound in India under different brand names.
Indian pharma giant Aurobindo Pharma establishes new subsidiary in Chile, marking strategic expansion across South American markets with focus on branded prescriptions and over-the-counter medicines.
In a major pharmaceutical industry move, Torrent Pharmaceuticals receives Competition Commission of India approval to acquire controlling stake in JB Chemicals & Pharmaceuticals, marking significant consolidation in Indian pharma sector.
A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.
Major egg recall alert! Black Sheep Egg Company pulls products from US markets after FDA detects potential salmonella contamination. Stay informed and check your refrigerator.
Foodynamics issues urgent recall of pet treats across Wisconsin, New York, and Florida following potential salmonella contamination. Learn which products are affected and how to protect your pets.
Danish pharma giant Novo Nordisk, the company behind diabetes & weight-loss blockbusters Ozempic and Wegovy, announces a major boardroom reshuffle. Get the inside scoop on the new faces and strategic direction.
Meet the trailblazing female entrepreneurs who built healthcare empires from scratch and are reshaping medical innovation worldwide. Discover their inspiring journeys to billions.
Delhi Police uncovers how Nigerian drug cartels are recruiting Indian students from pharma colleges, providing specialized training, and creating sophisticated dispatch systems to smuggle narcotics globally.
Expert analysis compares Zydus Lifesciences and Rubicon Research in the booming Indian pharmaceutical sector. Discover key financial metrics, growth drivers, and investment outlook for these promising stocks.
India's pharmaceutical sector gears up for Q2 FY25 with projected 5-7% revenue growth, navigating US pricing pressures and domestic GST reductions while maintaining stable profitability.
In a major breakthrough, Narcotics Control Bureau uncovers sophisticated drug manufacturing unit in Madhya Pradesh's Ratlam district. Highly educated pharma graduates among those arrested in interstate narcotics operation.
India mandates safety QR codes on all essential medicines in public healthcare, transforming drug safety and combating counterfeit drugs with digital innovation.
Madhya Pradesh's Special Investigation Team gears up for significant arrests in the Sresan Pharma cough syrup case that claimed young lives. Exclusive details on the expanding investigation.
In a landmark judgment, India's Supreme Court allows Natco Pharma to produce affordable generic version of Roche's expensive spinal muscular atrophy treatment, making life-saving therapy accessible to thousands.
Major health alert as FDA discovers hazardous lead levels in multiple ground cinnamon brands. Find out which products are affected and the serious health risks involved.